Total Assets - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Total Assets Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Total Assets
zł404.8m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Total Assets
zł5.5m
CAGR 3-Years
-34%
CAGR 5-Years
-22%
CAGR 10-Years
-8%
M
Medicofarma Biotech SA
WSE:MDB
Total Assets
zł16.4m
CAGR 3-Years
245%
CAGR 5-Years
58%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Total Assets
zł638.9m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Total Assets?
Total Assets
404.8m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Total Assets amounts to 404.8m PLN.

What is Ryvu Therapeutics SA's Total Assets growth rate?
Total Assets CAGR 5Y
9%

Over the last year, the Total Assets growth was -10%. The average annual Total Assets growth rates for Ryvu Therapeutics SA have been 13% over the past three years , 9% over the past five years .

Back to Top